Clinical Trial Update: Zoladex Plus Tamoxifen in Breast Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating the combination of Zoladex (goserelin) and Tamoxifen in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)
• Zoladex (goserelin)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Mammography, Estrogen | NA | Status: COMPLETED